Cancer Immunotherapy News and Research

RSS
Therapeutic potential of CD20 x CD3 bispecific antibodies

Therapeutic potential of CD20 x CD3 bispecific antibodies

Predicting treatment response in common blood cancer with DNA methylation profiling

Predicting treatment response in common blood cancer with DNA methylation profiling

Clinical trial to test the feasibility of using at-home cancer immunotherapy

Clinical trial to test the feasibility of using at-home cancer immunotherapy

Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response

Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response

Scientists aim to understand why T cells do not sustain energy in tumors

Scientists aim to understand why T cells do not sustain energy in tumors

Study uncovers unexpected level of complexity hidden within neutrophils

Study uncovers unexpected level of complexity hidden within neutrophils

Breakthrough CRISPR technique unlocks insights about cancer immunology

Breakthrough CRISPR technique unlocks insights about cancer immunology

New approach detects T cells in "cold" tumors, paves way for broader immunotherapy

New approach detects T cells in "cold" tumors, paves way for broader immunotherapy

Novel drug combination shows promise for treating advanced skin cancers in kidney transplant recipients

Novel drug combination shows promise for treating advanced skin cancers in kidney transplant recipients

New immunotherapy target activin receptor 1C shows promise against cancer

New immunotherapy target activin receptor 1C shows promise against cancer

ESMO Congress 2024: Shaping the future of anticancer therapies

ESMO Congress 2024: Shaping the future of anticancer therapies

Aging alters fibroblasts to promote pancreatic cancer growth

Aging alters fibroblasts to promote pancreatic cancer growth

Unveiling the role of CD24-Siglec10 axis in tumor immune evasion

Unveiling the role of CD24-Siglec10 axis in tumor immune evasion

Innovative immunotherapy targets rare melanoma subtypes

Innovative immunotherapy targets rare melanoma subtypes

Researchers develop enhanced immunotherapy for multiple myeloma treatment

Researchers develop enhanced immunotherapy for multiple myeloma treatment

Novel approach improves CAR T-cell therapy efficacy against acute myeloid leukemia

Novel approach improves CAR T-cell therapy efficacy against acute myeloid leukemia

New immunotherapy borrows cancer's tricks to unleash powerful T cells

New immunotherapy borrows cancer's tricks to unleash powerful T cells

Study reveals "dormancy" of natural killer cells in tumors

Study reveals "dormancy" of natural killer cells in tumors

New workflow identifies shared cancer targets, advancing immunotherapy

New workflow identifies shared cancer targets, advancing immunotherapy

LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis

LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.